Lv1
25 积分 2021-11-18 加入
Meta‐analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene ( PNPLA3 ) on the susceptibility and histological severity of nonalcoholic fatty liver disease
4天前
已完结
Statin use and non-alcoholic steatohepatitis in at risk individuals
29天前
已完结
Statin use and non-alcoholic steatohepatitis in at risk individuals
1个月前
已完结
Genetics and Epigenetics in the Clinic: Precision Medicine in the Management of Fatty Liver Disease
1个月前
已完结
The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage
1个月前
已完结
Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice
1个月前
已完结
Resmetirom's Approval: Highlighting the Need for Comprehensive Approaches in NASH Therapeutics
1个月前
已完结
Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment
1个月前
已完结
NAFLD and NASH: etiology, targets and emerging therapies
1个月前
已完结
Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis
2个月前
已完结
皖公网安备34019202002308
